[1] Tanoue LT,Detterbeck FC. New TNM classification for non small cell lung cancer[J]. Expert Rev Antieancer Ther,2009,9 (4 ):413-423.
[2] 王静,武淑英,顾莹,等. 葡萄胎中CDKN2A 基因纯合性缺失和 突变的研究[J]. 中国肿瘤临床,2 008,3 5(3):145-148.
[3] Abbaszadegan MR,Moaven O,Sima HR,et al. p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer[J]. World J Gastroenterol,2008,1 4(13):2055-2060.
[4] Koscielny S,Dahse R,Ernst G, et al. The prognostic relevance of p16 inactivation in head and neck cancer [J]. ORL J Otorhinolaryngol Relat Spec,2007, 69(1):30-36.
[5] 白同,杨斌,娄诚,等. APC 和CDKN2A 基因甲基化定量分析对 肝细胞癌的诊断价值[J]. 世界华人消化杂志,2 009,1 7(29):3001-3007.
[6] Giefing M,Martin-Subero JI,Kiwerska K, et al. Characterization of homozygous deletions in laryngeal squamous cell carcinoma cell lines[J]. Cancer Genet Cytogenet,2008,1 84(1):38-43.
[7] Guo XQ,Wang SJ,Zhang LW, et al. DNA methylation and loss of protein expression in esophageal squamous cell carcinogenesis of high-risk area[J]. J Exp Clin Cancer Res,2007,26 (4 ):587-594.
[8] 李林,陈晓锐,宋莎莎,等. PDCD4 基因在过氧化氢诱导喉癌 细胞凋亡中的作用[J]. 中国组织化学与细胞化学杂志, 2010, 19(1):72-76.
[9] Brock MV,Hooker CM,Ota-Machida E, et al. DNA methylation markers and early recurrence in stage Ⅰ lung cancer[J]. N Engl J Med,2008,3 58(11):1118-1128.
[10] Kiwerska K,Rydzanicz M,Kram A, et al. Mutational analysis of CDKN2A gene in a group of 390 larynx cancer patients[J]. Mol Biol Rep,2010(37):325-332.
[11] 梁晓东,关超. p16 基因在喉鳞癌中的表达及其临床意义[J]. 中国眼耳鼻肺科杂志,2 008,8 (5):292-294.